- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic Castration-resistant Prostate Cancer (mCRPC)
Total 1172 results
-
University of California, San FranciscoConquer Cancer FoundationCompletedProstate Cancer | Metastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
Suzhou Kintor Pharmaceutical Inc,CompletedMetastatic Hormone-Sensitive Prostate Cancer (mHSPC) | Metastatic Castrate Resistant Prostate Cancer (mCRPC)United States
-
Northwestern UniversityRecruitingMetastatic Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Refractory Prostate Cancer | Castration-Resistant Prostatic CancerUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Epizyme, Inc.; PfizerActive, not recruitingMetastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
Epizyme, Inc.Active, not recruitingMetastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Spain, Belgium
-
Tianjin Medical University Second HospitalUnknownMetastatic Cancer | Castration-resistant Prostate CancerChina
-
University of PennsylvaniaProstate Cancer FoundationRecruiting
-
Merck Sharp & Dohme LLCCompletedMetastatic Castration-resistant Prostate Cancer
-
Rahul AggarwalNational Institute of Mental Health (NIMH); U.S. Army Medical Research Acquisition...RecruitingSolid Tumor | Castration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Solid Tumor, Adult | Metastatic Castration-resistant Prostate CancerUnited States
-
AstraZenecaCompletedMetastatic Castration-resistant Prostates CancerIndia, Peru, Saudi Arabia, Egypt, Colombia, Korea, Republic of, Turkey, United Arab Emirates
-
Astellas Pharma IncMedivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration-Resistant Prostate Cancer (CRPC)United States, Moldova, Republic of, South Africa
-
Northwestern UniversityNational Cancer Institute (NCI); AstraZenecaActive, not recruitingMetastatic Prostate Carcinoma | Stage IV Prostate Cancer | Prostate Cancer Metastatic Castration-Resistant | Abnormal DNA RepairUnited States
-
BayerCompletedNon-metastatic Prostate Cancer | Non-metastatic Castration-resistant Prostate CancerUnited States
-
BayerRecruitingMetastatic Castrate Resistant Prostate Cancer (mCRPC)Czechia, France, Hungary, Italy, Poland, Spain, Taiwan, United Kingdom, Korea, Republic of, Singapore, Hong Kong, Australia, Finland, Germany, Israel, Lithuania, Russian Federation, Turkey, Austria
-
Hinova Pharmaceuticals USA, Inc.Active, not recruitingCastration-resistant Prostate Cancer | Prostate Cancer MetastaticGermany, Spain, Denmark, France, United Kingdom, Russian Federation, Poland, Australia, Italy, Netherlands, United States, Finland, Canada, Austria
-
Centre Francois BaclesseNational Cancer Institute, FranceCompletedMetastatic Castration-resistant Prostate Cancer (CRPCa)France
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKline; University of WashingtonCompletedProstate Cancer | Castration-resistant, MetastaticUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)UnknownCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Castration Levels of Testosterone | Prostate Carcinoma Metastatic in the BoneUnited States
-
Modra PharmaceuticalsCompletedCastration-resistant Prostate Cancer | Prostate Cancer MetastaticUnited States, Germany, Hungary, Poland, Russian Federation, Czechia
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers SquibbCompletedProstate Cancer | Castration-resistant Prostate Cancer | Metastatic Prostate CancerUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Cancer Immunotherapy Trials NetworkCompletedCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer | Castration Levels of TestosteroneUnited States
-
AstraZenecaCompletedMetastatic Castrate-Resistant Prostate Cancer (mCRPC), | Efficacy, | Safety and Tolerability, | Pharmacokinetics, | Pharmacodynamics, | Tumour Response.United Kingdom, United States
-
Rashmi Verma, MDNational Cancer Institute (NCI)RecruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Adenocarcinoma | Stage IVB Prostate Cancer American Joint Committee on Cancer (AJCC) v8United States
-
Fudan UniversityRecruitingCastration-resistant Prostate Cancer | Prostate Cancer MetastaticChina
-
Sir Mortimer B. Davis - Jewish General HospitalRecruitingCastration-resistant Prostate Cancer | Metastatic Prostate CancerCanada
-
Queen's University, BelfastHSC Public Health AgencyCompletedCastration-resistant Prostate Cancer | Prostate Cancer MetastaticUnited Kingdom
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingProstate Cancer | Castration-resistant Prostate Cancer | Prostate Adenocarcinoma | Prostate Cancer Metastatic | Prostate NeoplasmUnited States
-
BayerNot yet recruitingNon-metastatic Castration-resistant Prostate Cancer | Metastatic Hormone-sensitive Prostate CancerKorea, Republic of
-
Promontory Therapeutics Inc.Active, not recruitingUrogenital Neoplasms | Neoplasms by Site | Genital Neoplasms, Male | Prostatic Neoplasms | Advanced Solid Tumors | mCRPC | Metastatic Castrate-resistant Prostate Cancer | CRPC | PT-112United States, France
-
University of WashingtonNational Cancer Institute (NCI)CompletedCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer | PSA Progression | Castration Levels of Testosterone | Prostate Carcinoma Metastatic in the BoneUnited States
-
University of Michigan Rogel Cancer CenterMemorial Sloan Kettering Cancer Center; University of California, San FranciscoActive, not recruitingSolid Tumor | Metastatic Cancer | Metastatic Castration Resistant Prostate CancerUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingProstate Cancer Castration-resistant Prostate CancerChina
-
Fusion Pharmaceuticals Inc.RecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Norroy Bioscience Co., LTDRecruitingMetastatic Castration-resistant Prostate CancerChina
-
Peking Union Medical College HospitalRecruitingMetastatic Castration-resistant Prostate CancerChina
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingMetastatic Castration-resistant Prostate Cancer
-
Hinova Pharmaceuticals Inc.RecruitingMetastatic Castration-resistant Prostate CancerChina
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaRecruitingProstatic Neoplasms | Metastatic Castration-Resistant Prostate CancerChina
-
Yale UniversityDendreonRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
University of UtahRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Erasmus Medical CenterRecruitingMetastatic Castration-resistant Prostate CancerNetherlands
-
Lava TherapeuticsMerck Sharp & Dohme LLCRecruitingMetastatic Castration Resistant Prostate CancerUnited States, Spain, Netherlands
-
Robert Flavell, MD, PhDUnited States Department of Defense; Fortis Therapeutics, Inc.RecruitingProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
University of California, San DiegoRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Peter MacCallum Cancer Centre, AustraliaRecruitingProstate Cancer | Metastatic Castration-resistant Prostate CancerAustralia
-
University of UtahAstellas Pharma IncRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Istituto Scientifico Romagnolo per lo Studio e...BayerRecruitingMetastatic Castration-resistant Prostate CancerItaly
-
Institute of Cancer Research, United KingdomSun Pharmaceutical Industries LimitedTerminatedMetastatic Castration Resistant Prostate CancerUnited Kingdom, Switzerland
-
AstraZenecaMerck Sharp & Dohme LLCActive, not recruitingMetastatic Castration-resistant Prostate CancerChina
-
Peter MacCallum Cancer Centre, AustraliaActive, not recruitingProstate Cancer | Metastatic Castration-resistant Prostate CancerAustralia